Shots:
- The US FDA has granted clearance to the Magnetic EEG-guided Resonance Therapy (MeRT) System, a personalized, biomarker-guided neuromodulation technology for Post-Traumatic Stress Disorder (PTSD)
- Clearance was supported by a trial conducted with investigators from Texas A&M Health Institute of Biosciences & Technology, demonstrating that MeRT significantly reduced PTSD symptom severity with clinically meaningful improvements following treatment
- MeRT uses a patient’s brain data to deliver personalized, biomarker-guided PTSD treatment through legally marketed devices & was granted FDA Breakthrough Device designation in 2024
Ref: PRnewswire | Image: Wave Neurosciences |Press Release
Related News: SpinaFX Receives the US FDA IDE Approval to Initiate Trial for Triojection Therapy
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
